News

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Ondas Holdings Inc. (ONDS) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.17 per share a year ago. These

Shares of Septerna SEPN surged 51% on May 14 after the company entered into an exclusive global collaboration and license agreement with Danish pharma company, Novo Nordisk NVO, for developing and

AbbVie ABBV announced that the FDA has granted accelerated approval to its antibody-drug conjugate (ADC), telisotuzumab vedotin (or Teliso-V), for treating certain patients with non-small cell lung

For investors seeking momentum, Simplify Interest Rate Hedge ETF PFIX is probably on the radar. The fund just hit a 52-week high and has moved up 63% from its 52-week low of $37.00 per share. Are

STERIS plc STE reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $2.74, up 13.7% from the year-ago quarter’s figure. The figure surpassed the Zacks Consensus Estimate by 5.8%.

Leidos Holdings, Inc. LDOS, with rising earnings estimates, robust ROE, a solid backlog and shareholder-friendly initiatives, offers a great investment opportunity in the Zacks Aerospace Defense

Tullow Oil plc TUWOY, a London-based independent exploration and production company, has announced the sale of its entire portfolio of assets in Gabon. The company has signed a sale and purchase

Agnico Eagle Mines Limited AEM recently announced an agreement to subscribe for 30,000,000 voting common shares of Foran Mining Corporation through a non-brokered private placement at a price of

Shares of Lockheed Martin Corp. LMT have plunged 15.9% in the past six months, underperforming the Zacks Aerospace-Defense industry’s growth of 8.5% and the broader Zacks Aerospace sector’s rise of

The Boeing Company BA recently secured an order from AviLease, a Saudi Arabian aircraft lessor, to supply 20 of its 737-8 aircraft, with options to deliver 10 more. This contract win should

In value analysis, though price to earnings (P/E) and price to sales (P/S) are most preferred by investors, the underrated price-to-book ratio (P/B ratio) is also an easy-to-use valuation tool for

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across

How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across

Blackstone BX, one of the world’s largest alternative asset managers, has faced growing investor skepticism in recent months. The stock has declined 14% year to date, significantly underperforming

Evergy EVRG continues to benefit from the expansion of operations in the transmission market through collaborations, strategic acquisitions and partnerships. Through planned investments and the

Kinross Gold Corporation KGC has acquired a total of 7,574,237 units of Eminent Gold Corp., paying 40 cents per unit for a total investment of around $3 million. This transaction was pursuant to the

For Immediate Release

Chicago, IL – May 15, 2025 – Zacks Equity Research shares Comfort Systems USA FIX as the Bull of the Day and Target TGT as the Bear of the Day. In addition, Zacks Equity

LM Funding America, Inc. (LMFA) came out with a quarterly loss of $1.05 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.84 per share a year ago. These

ConocoPhillips COP, a leading upstream energy firm in terms of production and reserves, is well-positioned to capitalize on handsome crude prices. Currently, the firm carries a Zacks Rank #3 (Hold)

Mersana Therapeutics, Inc. (MRSN) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.16 per share a year ago. These

Invivyd, Inc. (IVVD) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.38 per share a year ago. These figures are